The BRAF mutation was detected in approximately 2.6% (303/11,711) of the population, which is consistent with previous research.[24,38] The reported rate of BRAF gene mutation ranges from 2% to 5%, similar to the mutation rate observed in our study.[21,22] Our study aimed to enhance the analysis of tumor mutations and examine the characteristics of NSCLC. The gene discussed is BRAF; the disease is neoplasm.